- Home
- WAVE vs TENX Comparison
WAVE vs TENX Comparison
Compare WAVE & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WAVE | TENX |
|---|---|---|
| Founded | 2011 | 1967 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.5M | 56.2M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | WAVE | TENX |
|---|---|---|
| Price | $5.40 | $15.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $15.00 | ★ $22.50 |
| AVG Volume (30 Days) | 10.6K | ★ 314.8K |
| Earning Date | 03-02-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $168,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $400.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.41 | $4.63 |
| 52 Week High | $10.90 | $18.38 |
Technical Indicators
Market Signals| Indicator | WAVE | TENX |
|---|---|---|
| Relative Strength Index (RSI) | 30.74 | 62.31 |
| Support Level | $5.90 | $11.06 |
| Resistance Level | $6.01 | $18.38 |
| Average True Range (ATR) | 0.28 | 1.59 |
| MACD | -0.01 | 0.18 |
| Stochastic Oscillator | 7.57 | 63.80 |
Price Performance
Historical ComparisonAbout WAVE Eco Wave Power Global AB (publ)
Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographical presence in Israel, USA and Mexico.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.